EP2101

BIOLOGICAL2 trials

Sponsors

Epimmune

Conditions

Carcinoma, Non-Small-Cell LungColonic NeoplasmsColorectal NeoplasmsLung Neoplasm

Phase 1

An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

CompletedNCT00054899

EpimmuneCarcinoma, Non-Small-Cell Lung, Lung Neoplasm

Start: 2003-01-31Target: 18Updated: 2010-03-24

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

CompletedNCT00054912

EpimmuneColonic Neoplasms, Colorectal Neoplasms

Start: 2003-02-28Target: 18Updated: 2008-04-09